Navigation Links
Fourth Annual Spine Technology Awards to Recognize Excellence and Innovation
Date:7/10/2012

WAYNE, Pa., July 10, 2012 /PRNewswire/ -- This October the Spine Technology Awards will recognize the best spine products, engineering teams and inventors for 2012. The first awards of their kind, the Fourth Annual Spine Technology Awards will focus exclusively on rewarding excellence and innovation.

Awards will be presented in five categories: device technologies for Cervical Care, Thoracolumbar Care, Motion Preservation of the Spine, Minimally Invasive Spine Care, Biomaterials and Biologics.

Any company that produces products for use in spine surgery may enter in one or more of the five categories. Judging by surgeons will be based on originality, clinical relevance, and the likelihood that the technology will improve current standards of care. The deadline for submission of entries is August 31, 2012. The winning entries will be revealed in Dallas, October 24-27, 2012.

Presented by Orthopedics This Week, the premier online orthopedics newsletter, and RRY Publications, the Spine Technology Awards are intended to bring increased recognition to exemplary and innovative spine surgery products and the engineering teams and inventors who create them.

In the words of Orthopedics This Week founder Robin Young, "Patients, physicians, hospitals, and reimbursers rely on the inspiration and perspiration of engineers and surgeon-inventors to improve outcomes and to control costs. Most engineers and inventors are little known, so we are proud to provide awards and a venue to recognize their great talents and contributions."

For more information about the Awards or to obtain an entry form, contact Suzanne Kirchner at suzanne@ryortho.com.

Entry Rules:  Technologies that are eligible for a 2012 Spine Technology Award are any device, pharmaceutical or biologic product that was developed to improve the care of patients with spine disease. The owners of the technology must have applied for patent protection within the 36 months prior to the awards ceremony (after October 24, 2009). The technology must be new to commercial use. Specifically, the technology need not be FDA cleared or approved. But, if the technology IS FDA approved or cleared, it will have had fewer than 24 months of commercial use prior to the awards ceremony.

RRY PUBLICATIONS LLC publishes Orthopedics This Week (www.ryortho.com) and hosts the annual Stem Cell Summit.

CONTACT:

Robin Young
RRY Publications LLC
Ph.: 610-260-6449
Fax: 610-260-6451


'/>"/>
SOURCE RRY Publications LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Bacterin International Signs Its Fourth National GPO Contract with the Premier healthcare alliance
2. Cardinal Health To Release Fourth-Quarter And Full-Year Results For Fiscal Year 2012 On Aug. 2
3. CareFusion To Report Fourth Quarter And Fiscal 2012 Results On Aug. 9
4. ResMed Announces Conference Call And Webcast To Discuss Fourth Quarter And Fiscal Year-End 2012 Results
5. Kewaunee Scientific Reports Significantly Improved Results for Fourth Quarter
6. Uroplasty Reports Fiscal Fourth Quarter And Full Year 2012 Financial Results
7. 3-V Biosciences To Present at the Seventh Annual JMP Securities Healthcare Conference
8. Insmed To Present At JMP Securities 7th Annual Healthcare Conference
9. Anthera Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
10. Arena Pharmaceuticals to Present at the Seventh Annual JMP Securities Healthcare Conference
11. Depomed To Present At JMP Securities 7th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... Md. , July 11, 2017  The global ... estimated revenues of approximately $394.1 million in 2016.  Although ... trend of solid growth, in particular as a result ... clinical practice, and the recent introduction of a significant ... need for less-invasive testing of tumor biomarkers to guide ...
(Date:7/11/2017)... 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug delivery ... Administration (FDA) has agreed to schedule an End-of-Phase II ... trial of its oral insulin capsule ORMD-0801 in the ... met primary and secondary endpoints by indicating a statistically ...
(Date:7/10/2017)... , July 10, 2017  BDI Group ... and patient support services organization serving specialty pharmacies, ... the launch of four significant, value-added member programs ... insights, better manage reimbursement and improve access and ... factor therapies. ...
Breaking Medicine Technology:
(Date:7/25/2017)... ... July 25, 2017 , ... ... announced it will be exhibiting and providing demos of its smart journaling platform ... Washington Convention Center in Washington D.C. from August 3-6, 2017. , The APA ...
(Date:7/25/2017)... Jacksonville, Fla. (PRWEB) , ... July 25, 2017 , ... ... employee and father Ezra Clark is taking advantage of a new benefit for employees ... “It really means a lot that the company supports me and other employees as ...
(Date:7/24/2017)... Florida (PRWEB) , ... July ... ... Division Marketing Director,      (407) 916-7235, kklaproth(at)robinsmorton(dot)com , Robins & ... joined together to celebrate the structural topping out of the new Destination ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... federal Substance Abuse and Mental Health Services Administration’s (SAMHSA) State Targeted Response to ... Department of Health Care Services, will facilitate the development of a hub and ...
(Date:7/24/2017)... ... ... The International Essential Tremor Foundation (IETF) will host a free educational forum in ... take place on Saturday, Aug. 26 at the Embassy Suites by Hilton Cleveland Rockside ... a.m. to 12 p.m., with check-in beginning at 8 a.m. The event is sponsored ...
Breaking Medicine News(10 mins):